Phosphate Binders in CKD: ‟New Kids on the Block”
DOI:
https://doi.org/10.53778/pjkd31089Ključne reči:
hyperphosphatemia, mineral bone disease, sevelamer, ferric sitrate, lanthanum, sucro ferricoxyhydroxideApstrakt
Phosphate control is essential component of dietary and medical management of chronic kidney disease (CKD) patients. Hyperphosphatemia has a significant effect on morbidity and mortality of CKD patients. This review takes us through the different older and newer medications available for management of hyperphosphatemia.
Preuzimanja
Objavljeno
Broj časopisa
Rubrika
Licenca
Sva prava zadržana (c) 2021 Muhammad Umair Afzal, Shafeeq Cheema

Ovaj rad je pod Creative Commons Autorstvo-Nekomercijalno 4.0 Internacionalna licenca.
